Biospective specializes in providing state-of-the-art biomarkers to the pharmaceutical and biotechnology industries. Biospective offers a broad range of pre-clinical services for biodistribution and efficacy studies including:

CNS DISEASE MODELS
• Multiple sclerosis
• Alzheimer’s disease

ONCOLOGY MODELS
• Mouse & rat (nude and immunocompetent)
• Xenograft models (subcutaneous and orthotopic)
• Orthotopic brain tumor models

OUR BIOMARKERS

By combining multiple biomarkers, such as MRI, PET, autoradiography, histology, and immunohistochemistry, we are able to provide a comprehensive structural, functional, and molecular characterization of the biological effects of therapeutic agents. At Biospective, we work closely with our clients on study design in order to ensure the highest possible quality studies.

Our unique combination of pre-clinical and clinical imaging services provides a seamless translation from pre-clinical studies to early phase clinical trials